Utah Medical Products, Inc. Extends Tender Offer
SALT LAKE CITY, UT / ACCESS Newswire / October 5, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75.00 per share. The Offer was initially scheduled to expire at 5:00 p.m. New York City time, on Wednesday October 7. In order to allow all stockholders sufficient time to make their decisions, UTMD is extending the expiration date to 5:00 p.m. New York City time, on Tuesday October 27. The time extension provides the added benefit of allowing stockholders to consider UTMD's latest financial results for calendar 3Q 2026 which are scheduled to be announced on Thursday October 22.
Except for the extended expiration date, all the conditions of the Offer remain the same and are explained in detail by reference in the SEC Form TO-IA Offer to Purchase and Letter of Transmittal filed with the SEC at
https://www.sec.gov/Archives/edgar/data/706698/000109690626001481/0001096906-26-001481-index.htm
The Letter of Transmittal and certificates for Shares and any other required documents should be sent or delivered by each stockholder or his or her broker, dealer, commercial bank, trust company or other nominee to the Depositary at its address set forth below. The Depositary for the Offer is:
| Computershare Trust Company, N.A. | |
| P.O. Box 43011 | |
| Providence, RI 02940-3100 | |
| Attn: Voluntary Corporate Actions |
Additional copies of the Offer to Purchase, the Letter of Transmittal or other tender offer materials may be obtained from the Information Agent and will be furnished at the Company's expense. Questions and requests for assistance concerning the Offer should be directed to the Information Agent:
| Georgeson LLC | |
| 51 West 52nd Street, 6th Floor | |
| New York, NY 10019 | |
| Call Toll Free: (866) 920-7258 |
Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long-term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD's website atwww.utahmed.com.
Contact:
Brian Koopman
(801) 566-1200
SOURCE: Utah Medical Products, Inc.
View the original press release on ACCESS Newswire
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
The 10 Best Companies to Invest in Now
14 Elite Funds and ETFs, and 5 Popular Funds That Just Missed the Mark
The Top Funds for a Simpler Retirement Portfolio
3 Stocks to Sell and 3 Stocks to Buy for October
United States